PPA overview

Contract model and parties

Model:

Physical (on-site)

Generator:

Mitsubishi HC Capital Energy Inc.

三菱HCキャピタルエナジー株式会社

Offtaker:

ASKA Pharmaceutical

あすか製薬株式会社

Industry:

Pharmaceutical Manufacturing

Capacity and generation

T&D area:

Tohoku

Technology:

Solar

Capacity:

-

Inverter:

-

Generation:

Status and timeline

Status:

Live

*

Disclosed:

June 19, 2023

COD:

2024 spring (expected)

Duration:

Undisclosed

* Presumed live based on the expected COD.

Additional details

  • Mitsubishi HC Capital Energy will set up a solar power plant at ASKA Pharmaceutical Iwaki Factory
  • The PPA is expected to result in approximately 440t annual reduction of CO2 emissions

Mitsubishi HC Capital Energy Inc.'s other PPAs

ASKA Pharmaceutical's other PPAs

Monthly Report - The Japanese Power Industry Executive

Submit the form below to receive a sample issue of The Japan Power Industry Executive.